Bio-Hacking Stability: Why Willpower is a Failed Strategy for Executives
Published July 2, 2025
By Sophie Solmini, ICADC, MATS · 15 Years in Private Substance Crisis Work

He had tried to stop on his own three times before I was involved. Not half-heartedly. With the same discipline he applied to everything else in his life. He had restructured his schedule, removed alcohol from the house, told his wife this time was different. Each attempt lasted weeks before it did not. This is the pattern I describe in why just stopping fails.
He was not lacking in willpower. He had more of it than most people I work with. The problem was that willpower was the wrong instrument for what was actually happening in his biology.
Why Discipline Is the Wrong Instrument
This is the gap that the high-performance myth does not account for. The idea that overcoming dependency is fundamentally a matter of discipline is appealing to principals who have built their entire professional identity on the capacity to impose their will on difficult situations. It is also incorrect. Dependency restructures the brain's reward and stress response systems in ways that do not respond to determination. Trying to resolve a biological problem through psychological effort alone is not a character test. It is using the wrong tool for the job.
What changes the outcome is addressing the biology directly, alongside the behavioral and environmental work. This is where medical coordination becomes relevant, and it is a component of my practice that I want to be precise about because the boundaries matter.
I am not a physician. I do not prescribe medication and I do not provide medical advice. What I do is coordinate between the principal and the private medical team, and that coordination function is more consequential than it might sound. A physician treating a high-functioning executive for dependency needs to understand the actual conditions of that principal's life in order to design a protocol that will hold inside them. The travel schedule. The stress load. The specific windows in the day when the pattern is most active. The professional obligations that cannot be suspended for the treatment to accommodate. Without that context, the protocol is designed for a generic patient rather than for the person in front of me. My role is to ensure the medical team has what they need to be effective, and to provide the daily oversight that keeps the principal adherent to what has been prescribed.
Working With the Reward System, Not Against It
One of the most significant tools available to private physicians working in this space involves pharmacological approaches that work with the brain's reward system rather than against it. The Sinclair Method is the most established of these. It uses non-addictive medication to interrupt the reward signal that reinforces the pattern. The principal is not required to stop immediately. The medication is taken before drinking, the neurological reward is blocked, and over time the brain's association between the substance and pleasure gradually extinguishes. It is a data-driven process, which tends to appeal to principals who are comfortable with measurable outcomes and uncomfortable with approaches that ask them to accept things on faith.
What makes this approach particularly suited to this population is what it does not require. It does not require residential care. It does not require time away from professional obligations. It is managed within a standard physician-patient relationship, which means it carries the same confidentiality protections as any other private medical treatment. The principal does not appear anywhere that creates exposure. The treatment is integrated into the existing structure of his life rather than requiring that structure to be suspended. This is part of the broader In-Residence approach I use with principals who cannot step away.
What I Coordinate Around the Biology
My coordination role across a medically supported engagement has three distinct functions. The first is ensuring the physician has the operational picture they need to design the protocol correctly. The second is daily adherence oversight, because a protocol that is followed inconsistently produces inconsistent results, and accountability to a structured check-in is a meaningful part of what makes adherence hold. The third is the surrounding architecture. The physician handles the neurochemistry. I handle what surrounds it. The sleep protocols that support the medical plan. The transition rituals that replace the behavioral function the substance was serving. The environmental adjustments that reduce the conditions under which the pattern would otherwise reassert itself.
The principal I described at the beginning of this post did not find the answer in his fourth attempt at willpower. He found it when the biological component of what he was dealing with was addressed directly, alongside the structural and environmental work that the willpower attempts had not included. The combination held in a way that the determination alone had not.
This is not a story about weakness or discipline. It is a story about using the correct instrument for the problem that is actually present. Principals who are sophisticated enough to bring in the right specialist for every other domain of their professional life are capable of applying that same logic here. The biology is not a character flaw to be overcome. It is a variable to be managed, and managing it correctly changes what becomes possible.
About the Author
Sophie Solmini, ICADC, MATS
Sophie Solmini is an ICADC (International Certified Alcohol and Drug Counselor) and Medication-Assisted Treatment Specialist with 15 years of experience in private substance crisis work. She works with individuals who are not willing or able to enter residential programs, deploying wherever they are. Available globally.
Related Briefings

The Executive Blind Spot: Why High-Functioning Leaders Miss the Warning Signs
High-achieving professionals often miss the warning signs of behavioral liability. Learn why executive success can mask the problem and what metrics to watch.

Ozempic and the Quiet Drinker: What I See in Executive Cases
The press has decided GLP-1 medications are the next fix for executive drinking. The clinical reality I see is more uneven. A clinical recovery read on what the 2026 trials actually show, where the medication helps, and where it does not.

In-Role Stabilisation vs. Residential Rehab: A Decision Framework for Executives
Residential treatment and in-role stabilisation are not competing philosophies. A framework for executives across the Dubai, London, Geneva corridor.